Back to Journals » Neuropsychiatric Disease and Treatment » Volume 15

Cortical thinning and flattening in schizophrenia and their unaffected parents

Authors Yan J, Cui Y, Li Q, Tian L, Liu B, Jiang T, Zhang D, Yan H

Received 19 November 2018

Accepted for publication 1 March 2019

Published 12 April 2019 Volume 2019:15 Pages 935—946

DOI https://doi.org/10.2147/NDT.S195134

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 3

Editor who approved publication: Dr Yu-Ping Ning


Jing Yan,1 Yue Cui,2,3 Qianqian Li,1 Lin Tian,4,5 Bing Liu,2,3 Tianzi Jiang,2,3 Dai Zhang,1,6 Hao Yan1

1Peking University Sixth Hospital/Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, People’s Republic of China; 2Brainnetome Center/National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, People’s Republic of China; 3University of Chinese Academy of Sciences, Beijing 100049, People’s Republic of China; 4Department of Psychiatry, Wuxi Mental Health Center, Nanjing Medical University, Wuxi 214151, People’s Republic of China; 5Wuxi Mental Health Center, Wuxi Tongren International Rehabilitation Hospital, Nanjing Medical University, Wuxi, 214151, People’s Republic of China; 6Peking-Tsinghua Joint Center for Life Sciences & PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing 100871, People’s Republic of China

Background: Schizophrenia  is a neurodevelopmental disorder with high heritability. Widespread cortical thinning has been identified in schizophrenia, suggesting that it is a result of cortical development deficit. However, the findings of other cortical morphological indexes of patients are inconsistent, and the research on their relationship with genetic risk factors for schizophrenia is rare.
Methods: In order to investigate cortical morphology deficits and their disease-related genetic liability in schizophrenia, we analyzed a sample of 33 patients with schizophrenia, 60 biological parents of the patients, as well as 30 young controls for patients and 28 elderly controls for parents with age, sex and education level being well-matched. We calculated vertex-wise measurements of cortical thickness, surface area, local gyrification index, sulcal depth, and their correlation with the clinical and cognitive characteristics.
Results: Widespread cortical thinning of the fronto-temporo-parietal region, sulcal flattening of the insula and gyrification reduction of the frontal cortex were observed in schizophrenia patients. Conjunction analysis revealed that patients with schizophrenia and their parents shared significant cortical thinning of bilateral prefrontal and insula, left lateral occipital and fusiform regions (Monte Carlo correction, P<0.05), as well as a trend-level sulcal depth reduction mainly in bilateral insula and occipital cortex. We observed comprehensive cognitive deficits in patients and similar impairment in the speed of processing of their unaffected parents. Significant associations between lower processing speed and thinning of the frontal cortex and flattening of the parahippocampal gyrus were found in patients and their parents, respectively. However, no significant correlation between abnormal measurements of cortical morphology and clinical characteristics was found.
Conclusion: The results suggest that cortical morphology may be susceptible to a genetic risk of schizophrenia and could underlie the cognitive dysfunction in patients and their unaffected relatives. The abnormalities shared with unaffected parents allow us to better understand the disease-specific genetic effect on cortical development.

Keywords: schizophrenia, first-degree relatives, cortical thickness, sulcus depth, insula, speed of processing


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]